A Wetpaint Site | TV Fandex 100

Help Kasie Burtard

Stem Cell Policy: World Stem Cell Map

Disclaimer Countries colored in brown represent about 3.5 billion people, more than half the world's population. All have a permissive or flexible policy on human embryonic stem cell research and all have banned human reproductive cloning. Population: M = million.

Australia - 20.3 M
Belgium - 10.4 M
Brazil - 188 M
Canada - 33.1 M
China - 1,314 M
Czech Republic - 10.2 M
Denmark - 5.4 M
Estonia - 1.3 M
Finland - 5.2 M

France - 62.8 M
Greece - 10.7 M
Hong Kong - 6.9 M
Hungary - 10 M
Iceland - .3 M
India - 1,045 M
Iran - 69 M
Israel - 6.4 M
Japan - 127 M

Latvia - 2.3 M
The Netherlands - 16.5 M
New Zealand - 4.1 M
Portugal - 10.6 M
Russia - 146 M
Singapore - 4.5 M
Slovenia - 2.0 M
South Africa - 44 M
South Korea - 40.4 M

Spain - 40.4 M
Sweden - 9 M
Switzerland - 7.5 M
Taiwan - 23 M
Thailand - 65 M
Turkey* - 70 M
United Kingdom - 60.6 M

Map Explanation

"permissive" = various embryonic stem cell derivation techniques including somatic cell nuclear transfer (SCNT), also called research or therapeutic cloning. SCNT is the transfer of a cell nucleus from a somatic or body cell into an egg from which the nucleus has been removed. [Options 4 & 5 in Walters, LeRoy, in References, below] Countries in this category include Australia, Belgium, China, India, Israel, Japan, Singapore, South Korea, Sweden, the United Kingdom and others. [Walters, LeRoy, National Academy of Sciences, 2004; University of Minnesota, 2007. See References, below] These countries represent a global population of more than 2.7 billion people.
"flexible" = derivations from fertility clinic donations only, excluding SCNT, and often under certain restrictions. [Option 3 in Walters, LeRoy, in References, below: "Research is permitted only on remaining embryos no longer needed for reproduction."] Countries in this category include Brazil, Canada, France, Iran, South Africa, Spain, The Netherlands, Taiwan, and others. [Walters, LeRoy, National Academy of Sciences, 2004; University of Minnesota, 2007. See References, below] These countries represent a global population of more than 700 million people.
Restrictive policy or no established policy. For restrictive policy see Options 1 & 2 in Walters, LeRoy in References, below. Restrictive policies range from outright prohibition of human embryo research to permitting research on imported embryonic stem cell lines only to permitting research on a limited number of previously established stem cell lines. Countries with a restrictive policy include (among the most restrictive) Austria, Ireland, Norway, Poland, (among the less restrictive) Germany, Italy, and the United States.
Map is designed to reflect national policy and whether or not public funds may be used to pursue stem cell research using IVF embryos donated from fertility clinics.
The black dots show the locations of some of the leading genome sequencing research centers. Most U.S. centers are those that have been involved in the Human Genome Project. The genome sequencing centers are meant to indicate the level of scientific infrastructure and not whether stem cell genomic studies are being conducted at a given center. The dots are linked to center web sites.
California in the U.S. supports embryonic stem cell research through Proposition 71, a $3 billion bonding initiative that is projected to provide about $300 million in stem cell research funding annually for 10 years. Approved by California voters Nov. 2, 2004, Proposition 71 establishes a state constitutional right to pursue stem cell research, including through SCNT or research/therapeutic cloning, and prohibits funding of human reproductive cloning research. California Institute for Regenerative Medicine
Map is a Mercator projection that exaggerates the size of areas far from the equator. * Turkey is among several countries in which no specific regulations and guidelines have so far been defined by legal or governmental institutions for human embryonic stem cell research. Dr. Necati Findikli of Istanbul Memorial Hospital reported the first known derivation of human embryonic stem cells from donated blastocyst-stage embryos in Turkey in 2005. Reproductive Medicine Online 10 (5), 617-627, 2005

CODivegirl	Latest page update: made by CODivegirl , Jan 28 2009, 3:32 PM EST (about this update About This Update Moved from: Stem Cell Research & Therapy - CODivegirl No content added or deleted. - complete history)
	Keyword tags: None More Info: links to this page

Threads for this page

Post a new thread

There are no threads for this page. Be the first to start a new thread.